Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 195 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

REVIEW ARTICLE

Gemigliptin: Newer promising gliptin for type 2 diabetes mellitus

Gutch Manish, Joshi Abhay, Kumar Sukriti, Agarwal Avinash, Pahan Rajendra Kumar, Razi Syed Mohd

Year : 2017| Volume: 21| Issue : 6 | Page no: 898-902

   This article has been cited by
 
1 Current Pharmacological Intervention and Medical Management for Diabetic Kidney Transplant Recipients
Theerawut Klangjareonchai,Natsuki Eguchi,Ekamol Tantisattamo,Antoney J. Ferrey,Uttam Reddy,Donald C. Dafoe,Hirohito Ichii
Pharmaceutics. 2021; 13(3): 413
[Pubmed]  [Google Scholar] [DOI]
2 Exploring the recent molecular targets for diabetes and associated complications
Amit Gupta,Tapan Behl,Aayush Sehgal,Shaveta Bhardwaj,Sukhbir Singh,Neelam Sharma,Abdul Hafeez
Molecular Biology Reports. 2021; 48(3): 2863
[Pubmed]  [Google Scholar] [DOI]
3 Efficacy and Safety of the Novel Dipeptidyl Peptidase-4 Inhibitor Gemigliptin in the Management of Type 2 Diabetes: A Meta-Analysis
Deep Dutta,Anshita Agarwal,Indira Maisnam,Rajiv Singla,Deepak Khandelwal,Meha Sharma
Endocrinology and Metabolism. 2021; 36(2): 374
[Pubmed]  [Google Scholar] [DOI]
4 The vasodilatory effect of gemigliptin via activation of voltage-dependent K+ channels and SERCA pumps in aortic smooth muscle
Hee Seok Jung,Mi Seon Seo,Jin Ryeol An,Minji Kang,Ryeon Heo,Hongliang Li,Won-Kyo Jung,Il-Whan Choi,Eun-Hee Cho,Hongzoo Park,Young Min Bae,Won Sun Park
European Journal of Pharmacology. 2020; 882: 173243
[Pubmed]  [Google Scholar] [DOI]
5 Pharmacology of dipeptidyl peptidase-4 inhibitors and its use in the management of metabolic syndrome: a comprehensive review on drug repositioning
Maryam Rameshrad,Bibi Marjan Razavi,Gordon A. A. Ferns,Hossein Hosseinzadeh
DARU Journal of Pharmaceutical Sciences. 2019;
[Pubmed]  [Google Scholar] [DOI]
6 Potentiation of endothelium-dependent vasorelaxation of mesenteric arteries from spontaneously hypertensive rats by gemigliptin, a dipeptidyl peptidase-4 inhibitor class of anti-diabetic drug
Hae Jin Kim,Eun Bok Baek,Sung Joon Kim
The Korean Journal of Physiology & Pharmacology. 2018; 22(6): 713
[Pubmed]  [Google Scholar] [DOI]

 

Read this article